Safety and Tolerability of Liraglutide in Healthy Male Volunteers
Status:
Completed
Trial end date:
1999-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to assess the safety and
tolerability (maximum tolerated dose) after five ascending single doses of NNC 90-1170
(liraglutide).